CIPARGAMIN
Cipargamin is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target P-type sodium-transporting ATPase4.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
9 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Malaria | D008288 | EFO_0001068 | B54 | 3 | 6 | — | — | — | 9 |
| Falciparum malaria | D016778 | EFO_0007444 | B50 | 2 | 3 | — | — | — | 5 |
| Vivax malaria | D016780 | EFO_0007445 | B51 | — | 1 | — | — | — | 1 |
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | CIPARGAMIN |
| INN | cipargamin |
| Description | Cipargamin (NITD609, KAE609) is an experimental synthetic antimalarial drug belonging to the spiroindolone class. The compound was developed at the Novartis Institute for Tropical Diseases in Singapore, through a collaboration with the Genomics Institute of the Novartis Research Foundation (GNF), the Biomedical Primate Research Centre and the Swiss Tropical Institute.
|
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | C[C@H]1Cc2c([nH]c3cc(Cl)c(F)cc23)[C@@]2(N1)C(=O)Nc1ccc(Cl)cc12 |
Identifiers
| PDB | — |
| CAS-ID | 1193314-23-6 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1082723 |
| ChEBI ID | — |
| PubChem CID | 44469321 |
| DrugBank | — |
| UNII ID | Z7Q4FWA04P (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
ATP4
ATP4
Organism
Plasmodium falciparum (isolate 3D7)
Gene name
ATP4
Gene synonyms
NCBI Gene ID
—
Protein name
P-type sodium-transporting ATPase4
Protein synonyms
P-type cation-transporter ATPase4
Uniprot ID
Mouse ortholog
—
—
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 362 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use